On July 18, 2025, NanoVibronix, Inc. finalized a securities purchase agreement to sell 8,889 shares of Series H Convertible Preferred Stock and warrants to an institutional investor, raising $8 million intended for redeeming Series X Preferred Stock and working capital. The preferred stock is initially convertible into approximately 8.8 million shares of common stock at $1.01 per share, with potential further investment of up to $44 million from the investor within 36 months.